Zacks Research Brokers Increase Earnings Estimates for MOH

Molina Healthcare, Inc (NYSE:MOH – Free Report) – Stock analysts at Zacks Research increased their FY2026 earnings per share estimates for shares of Molina Healthcare in a report issued on Wednesday, November 11th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $5.27 for the year, up from their prior estimate of $5.25. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Molina Healthcare’s current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Molina Healthcare’s Q4 2026 earnings at $0.52 EPS, Q2 2027 earnings at $2.54 EPS, Q4 2027 earnings at $2.36 EPS, FY2027 earnings at $9.55 EPS, Q1 2028 earnings at $2.95 EPS, Q2 2028 earnings at $2.26 EPS and FY2028 earnings at $12.44 EPS.

MOH has been the topic of a number of other reports. Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, October 24th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Molina Healthcare in a report on Tuesday, October 27th. Morgan Stanley boosted their price objective on shares of Molina Healthcare from $167.00 to $192.00 and gave the company an “equal weight” rating in a research report on Friday, October 23rd. JPMorgan Chase & Co. boosted their price objective on shares of Molina Healthcare from $220.00 to $225.00 and gave the company a “neutral” rating in a research report on Tuesday, October 27th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $220.00 target price on shares of Molina Healthcare in a research note on Friday, October 23rd. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $213.88.

View Our Latest Report on Molina Healthcare

Molina Healthcare Stock Down 4.8%

Shares of MOH opened at $221.95 on Monday. The firm has a market capitalization of $11.59 billion, a P/E ratio of 116.54, a P/E/G ratio of 13.74 and a beta of 0.75. Molina Healthcare has a 12-month low of $121.06 and a 12-month high of $244.89. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95. The firm has a fifty day moving average price of $203.73 and a 200-day moving average price of $186.11.

Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The company had revenue of $11.08 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter in the prior year, the company posted $1.84 EPS. Molina Healthcare’s quarterly revenue was down 3.4% on a year-over-year basis.

Insider Transactions at Molina Healthcare

In related news, insider Jeff D. Barlow sold 8,000 shares of the company’s stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $203.07, for a total value of $1,624,560.00. Following the completion of the sale, the insider directly owned 59,313 shares of the company’s stock, valued at $12,044,690.91. This represents a 11.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven J. Orlando sold 702 shares of the stock in a transaction dated Monday, November 16th. The stock was sold at an average price of $227.33, for a total transaction of $159,585.66. Following the transaction, the director owned 17,569 shares in the company, valued at approximately $3,993,960.77. The trade was a 3.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 11,084 shares of company stock valued at $2,273,419 over the last 90 days. 1.44% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Molina Healthcare

Several hedge funds have recently modified their holdings of the business. BlackRock Inc. purchased a new position in Molina Healthcare during the second quarter worth approximately $1,503,052,000. Wellington Management Group LLP increased its position in Molina Healthcare by 11.9% during the second quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company’s stock worth $289,810,000 after purchasing an additional 135,247 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Molina Healthcare by 23.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock valued at $185,929,000 after purchasing an additional 267,121 shares during the last quarter. Manning & Napier Advisors LLC purchased a new stake in shares of Molina Healthcare in the 2nd quarter valued at approximately $152,339,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Molina Healthcare in the 2nd quarter valued at approximately $86,138,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Recent Molina Healthcare Headlines

Here are a few of the latest headlines about MOH:

  • Positive Sentiment: Investors rotated toward defensive healthcare names as riskier parts of the market weakened, lifting Molina alongside the sector. The company’s recent earnings update and reaffirmed 2026 adjusted earnings guidance may have provided additional support. Sector news
  • Positive Sentiment: Zacks highlighted favorable prospects for medical HMO companies, including Molina, citing established membership bases, digital innovation and acquisitions as potential industry supports. Zacks industry outlook
  • Negative Sentiment: Recent quarterly results were mixed despite beating analyst estimates: EPS was $0.89 versus $0.79 expected, but below $1.84 a year earlier, while revenue declined 3.4% year over year. This could temper optimism about the rally.

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

Recommended Stories

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.